title: [Hemolytic uremic syndrome as of 2013].
authors.forename: C
authors.initials: C
authors.lastname: Loirat
authors.forename: P
authors.initials: P
authors.lastname: Mariani-Kurkdjian
authors.forename: V
authors.initials: V
authors.lastname: Fremeaux-Bacchi
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002648:Child; D003967:Diarrhea / Q000188:drug therapy; D054324:Enterohemorrhagic Escherichia coli / Q000302:isolation & purification*; D058872:Epidemics; D004927:Escherichia coli Infections / Q000175:diagnosis* / Q000188:drug therapy; D005602:France / Q000453:epidemiology; D005858:Germany / Q000453:epidemiology; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007163:Immunosorbent Techniques; D010951:Plasma Exchange; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab